Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Baum

Showing results (291-300 of 470) with videos related to

Pageof 47
Sort By:
Neuroendocrinology|July 21, 2017
Morphological and Functional Imaging for Detecting and Assessing the Resectability of Neuroendocrine Liver MetastasesMaxime Ronot, Ashley K Clift, Richard P Baum, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
Effects of chronic administration of a monoclonal antibody against human renin in the marmosetJ M Wood, H P Baum, J P Bews, et al.
Drugs of Today (Barcelona, Spain : 1998)|November 22, 2012
Vandetanib therapy in medullary thyroid cancerP Grabowski, F Briest, R P Baum, et al.
Iscience|December 13, 2023
3BP-3940, a highly potent FAP-targeting peptide for theranostics - production, validation and first in human experience with Ga-68 and Lu-177Lukas Greifenstein, Annika Gunkel, Aileen Hoehne, et al.
Nuklearmedizin. Nuclear Medicine|August 1, 1997
[Simultaneous use of different nuclear medical examinations in Klippel-Trenaunay syndrome--vs. Proteus syndrome]T Rink, R P Baum, I Menzel, et al.
Minerva Gastroenterologica E Dietologica|December 5, 2012
Pancreatic neuroendocrine neoplasmsD Hörsch, T Bert, J Schrader, et al.
American Journal of Health Behavior|October 19, 2010
Accelerometry and self-report in sedentary populationsJennifer L Jovanovic, Daniel C Hughes, George P Baum, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1995
Semiquantitative SPECT tumor uptake of technetium-99m-labeled anti-CEA monoclonal antibody in colorectal tumorN Oriuchi, K Endo, N Watanabe, et al.
Blood|October 27, 1998
OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectorsY Ohshima, L P Yang, T Uchiyama, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 1987
[Immunoscintigraphy using 111In-DTPA-labeled monoclonal antibodies: comparison with ECT and planar scintigraphy]J Happ, R P Baum, J Frohn, et al.
Pageof 47

Showing results (291-300 of 470) with videos related to

Sort By:
Pageof 47
Neuroendocrinology|July 21, 2017
Morphological and Functional Imaging for Detecting and Assessing the Resectability of Neuroendocrine Liver MetastasesMaxime Ronot, Ashley K Clift, Richard P Baum, et al.
Clinical and Experimental Hypertension. Part A, Theory and Practice|January 1, 1987
Effects of chronic administration of a monoclonal antibody against human renin in the marmosetJ M Wood, H P Baum, J P Bews, et al.
Drugs of Today (Barcelona, Spain : 1998)|November 22, 2012
Vandetanib therapy in medullary thyroid cancerP Grabowski, F Briest, R P Baum, et al.
Iscience|December 13, 2023
3BP-3940, a highly potent FAP-targeting peptide for theranostics - production, validation and first in human experience with Ga-68 and Lu-177Lukas Greifenstein, Annika Gunkel, Aileen Hoehne, et al.
Nuklearmedizin. Nuclear Medicine|August 1, 1997
[Simultaneous use of different nuclear medical examinations in Klippel-Trenaunay syndrome--vs. Proteus syndrome]T Rink, R P Baum, I Menzel, et al.
Minerva Gastroenterologica E Dietologica|December 5, 2012
Pancreatic neuroendocrine neoplasmsD Hörsch, T Bert, J Schrader, et al.
American Journal of Health Behavior|October 19, 2010
Accelerometry and self-report in sedentary populationsJennifer L Jovanovic, Daniel C Hughes, George P Baum, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 1, 1995
Semiquantitative SPECT tumor uptake of technetium-99m-labeled anti-CEA monoclonal antibody in colorectal tumorN Oriuchi, K Endo, N Watanabe, et al.
Blood|October 27, 1998
OX40 costimulation enhances interleukin-4 (IL-4) expression at priming and promotes the differentiation of naive human CD4(+) T cells into high IL-4-producing effectorsY Ohshima, L P Yang, T Uchiyama, et al.
Nuklearmedizin. Nuclear Medicine|December 1, 1987
[Immunoscintigraphy using 111In-DTPA-labeled monoclonal antibodies: comparison with ECT and planar scintigraphy]J Happ, R P Baum, J Frohn, et al.
Pageof 47